Peritransplant Serum Albumin Decline Predicts Subsequent Severe Acute Graft-versus-Host Disease after Mucotoxic Myeloablative Conditioning.

[1]  R. Zeiser,et al.  Acute Graft-versus-Host Disease: Novel Biological Insights. , 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[2]  A. Rashidi,et al.  Early post-transplant contrast-enhanced abdominopelvic CT scan predicts the risk of subsequent acute GvHD , 2016, Bone Marrow Transplantation.

[3]  X. N. Wang,et al.  Identification and validation of biomarkers associated with acute and chronic graft versus host disease , 2015, Bone Marrow Transplantation.

[4]  M. Sorror,et al.  Design and Validation of an Augmented Hematopoietic Cell Transplantation-Comorbidity Index Comprising Pretransplant Ferritin, Albumin, and Platelet Count for Prediction of Outcomes after Allogeneic Transplantation. , 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[5]  B. Storer,et al.  Plasma biomarkers of acute GVHD and nonrelapse mortality: predictive value of measurements before GVHD onset and treatment. , 2015, Blood.

[6]  S. Rampelli,et al.  Gut microbiota trajectory in pediatric patients undergoing hematopoietic SCT , 2015, Bone Marrow Transplantation.

[7]  M. Pasquini,et al.  Pre-Transplant C-Reactive Protein (CRP), Ferritin and Albumin As Biomarkers to Predict Transplant Related Mortality (TRM) after Allogeneic Hematopoietic Cell Transplant (HCT) , 2014 .

[8]  A. Ganser,et al.  Proteomic peptide profiling for preemptive diagnosis of acute graft-versus-host disease after allogeneic stem cell transplantation , 2013, Leukemia.

[9]  N. Kröger,et al.  Serum albumin level predicts survival of patients with gastrointestinal acute graft-versus-host disease after allogeneic stem cell transplantation , 2014, Annals of Hematology.

[10]  C. Woods,et al.  Plasma microRNA signature as a noninvasive biomarker for acute graft-versus-host disease. , 2013, Blood.

[11]  T. Braun,et al.  ST2 as a marker for risk of therapy-resistant graft-versus-host disease and death. , 2013, The New England journal of medicine.

[12]  T. Feuth,et al.  Citrulline and albumin as biomarkers for gastrointestinal mucositis in recipients of hematopoietic SCT , 2013, Bone Marrow Transplantation.

[13]  R. Storb,et al.  Decreased serum albumin as a biomarker for severe acute graft-versus-host disease after reduced-intensity allogeneic hematopoietic cell transplantation. , 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[14]  I. Papassotiriou,et al.  Acute gastrointestinal graft-versus-host disease in pediatric patients: serum albumin on day 5 from initiation of therapy correlates with nonrelapse mortality and overall survival. , 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[15]  R. Bostick,et al.  Biomarkers of immune activation to screen for severe, acute GVHD , 2011, Bone Marrow Transplantation.

[16]  B. Cho,et al.  High levels of B cell activating factor during the peritransplantation period are associated with a reduced incidence of acute graft-versus-host disease following myeloablative allogeneic stem cell transplantation. , 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[17]  Thomas M Braun,et al.  A biomarker panel for acute graft-versus-host disease. , 2009, Blood.

[18]  G. Schoch,et al.  Albuminuria in hematopoietic cell transplantation patients: prevalence, clinical associations, and impact on survival. , 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[19]  S. Sohn,et al.  Prognostic factors identifiable at the time of onset of acute graft-versus-host disease after allogeneic hematopoietic cell transplantation. , 2004, Haematologica.

[20]  G. Hill,et al.  The primacy of the gastrointestinal tract as a target organ of acute graft-versus-host disease: rationale for the use of cytokine shields in allogeneic bone marrow transplantation. , 2000, Blood.

[21]  J. Crawford,et al.  Total body irradiation and acute graft-versus-host disease: the role of gastrointestinal damage and inflammatory cytokines. , 1997, Blood.

[22]  J. Klein,et al.  IBMTR Severity INDEX FOR GRADING ACUTE GRAFT‐VERSUS‐HOST DISEASE: RETROSPECTIVE COMPARISON WITH GLUCKSBERG GRADE , 1997, British journal of haematology.

[23]  F. Harrell,et al.  Prognostic/Clinical Prediction Models: Multivariable Prognostic Models: Issues in Developing Models, Evaluating Assumptions and Adequacy, and Measuring and Reducing Errors , 2005 .

[24]  S. Weisdorf,et al.  Graft-Versus-Host Disease of the Intestine: A Protein Losing Enteropathy Characterized by Fecal α1-Antitrypsin , 1983 .